HLX42

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX42, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HLX42 in Advanced/Metastatic Solid Tumors [Phase 1]